119 related articles for article (PubMed ID: 6844159)
1. Combined external radiotherapy and hormonal therapy for localized carcinoma of the prostate.
Mukamel E; Servadio C; Lurie H
Prostate; 1983; 4(3):283-7. PubMed ID: 6844159
[TBL] [Abstract][Full Text] [Related]
2. Early combined hormonal and chemotherapy for metastatic prostatic carcinoma.
Servadio C; Mukamel E; Lurie H; Nissenkorn I
Urology; 1983 May; 21(5):493-5. PubMed ID: 6857889
[TBL] [Abstract][Full Text] [Related]
3. Combined hormonal and radiation therapy for lymph node-positive prostate cancer.
Whittington R; Malkowicz B; Barnes MM; Broderick GA; Van Arsdalen K; Dougherty MJ; Wein AJ
Urology; 1995 Aug; 46(2):213-9. PubMed ID: 7542824
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy--5-year follow-up.
Giuliani L; Pescatore D; Giberti C; Martorana G; Natta G
Eur Urol; 1980; 6(3):145-8. PubMed ID: 7371659
[TBL] [Abstract][Full Text] [Related]
5. Early combined hormonal and chemotherapy for metastatic carcinoma of prostate.
Mukamel E; Nissenkorn I; Servadio C
Urology; 1980 Sep; 16(3):257-60. PubMed ID: 7423702
[TBL] [Abstract][Full Text] [Related]
6. Observations on surgical management of carcinoma of prostate with limited nodal metastases.
Zincke H; Utz DC
Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250
[TBL] [Abstract][Full Text] [Related]
7. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
8. Combined hormone-chemotherapy for metastatic prostatic carcinoma. Eleven-year follow-up.
Servadio C; Savion M; Mukamel E
Urology; 1987 Oct; 30(4):352-5. PubMed ID: 3660524
[TBL] [Abstract][Full Text] [Related]
9. The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma.
Sumi M; Ikeda H; Tokuuye K; Kagami Y; Murayama S; Tobisu K; Kakizoe T
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):519-28. PubMed ID: 10974471
[TBL] [Abstract][Full Text] [Related]
10. External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy.
Takada C; Ito K; Nishi J; Yamamoto T; Hatanaka Y; Baba Y; Takahashi M
Radiat Med; 1995; 13(6):297-300. PubMed ID: 8850371
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiotherapy following prostatectomy: results and complications.
Forman JD; Wharam MD; Lee DJ; Zinreich ES; Order SE
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):185-9. PubMed ID: 3949568
[TBL] [Abstract][Full Text] [Related]
12. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].
Fujii A; Oka N; Miyasaki S; Higuchi A; Tomioka O; Morishita S; Yamanaka K; Itoh N; Okamoto Y; Tanaka H
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1656-63. PubMed ID: 1722834
[TBL] [Abstract][Full Text] [Related]
15. Prostate brachytherapy: treatment strategies.
Stone NN; Stock RG
J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients.
Luo HC; Cheng HH; Lin GS; Fu ZC; Li DS
Asian Pac J Cancer Prev; 2013; 14(8):4711-5. PubMed ID: 24083731
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy of prostatic carcinoma].
Fuse H; Katayama T; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1991 Aug; 37(8):801-8. PubMed ID: 1659778
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the prostate in Israel: some epidemiological and therapeutic considerations.
Servadio C; Mukamel E; Kahan E
Prostate; 1984; 5(4):375-82. PubMed ID: 6739372
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy with or without androgen deprivation in the treatment of localized adenocarcinoma of the prostate.
Arcangeli G; Saracino B; Micheli A; D'Angelo L; Pansadoro V; Cruciani E; Marchetti P
Am J Clin Oncol; 1998 Feb; 21(1):1-5. PubMed ID: 9499247
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
